Second-generation anaplastic lymphoma kinase (ALK) inhibitors, including ceritinib, brigatinib, and alectinib, have improved survival in ALK-rearranged non-small-cell lung cancer (NSCLC) but are not ...

Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial For the model, we used ...

Lung cancer is the leading cause of cancer-related mortality worldwide, with most patients diagnosed at advanced stages. Early detection through screening can significantly reduce mortality, making ...

Independent analysis from energy experts at Charles River Associates shows that allowing public utility companies to generate energy would address supply and demand issues at heart of high energy ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Millions of Americans are struggling to keep up with rising utility ...